MGH Cellular Immunotherapy Program
Elevating Cellular Therapy
Welcome To The Maus Lab!
We are scientists with a passion for translating our laboratory findings into new therapies for cancer patients. Our goal is to understand what makes gene-modified T cells work well in patients, without significant toxicity, and to invent new forms of gene-modified immune cells to treat cancer. We work closely with our clinical colleagues to initiate clinical trials and derive patient samples to complete the bench-to-bedside-to-bench circle.
Established in 2015
As a physician and scientist, Dr. Maus is director of the Cellular Immunotherapy Program at Massachusetts General Hospital, which is the collaboration between physicians and laboratory scientists to implement safe and potent immunotherapies. The Maus lab continues to focus on discovering new ways to use cellular therapies to treat cancer.
Located at the Charlestown Navy Yard campus of Massachusetts General Hospital, we are members of the Harvard Medical School and Massachusetts General Hospital with collaborators at other MGB institutions, Dana-Farber Cancer Institute, Boston Children’s Hospital, Harvard and MIT, and centers around the country.